PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - G. S. Nowakowski; D. H. Yoon; E. Joffe; P. L. Zinzani; L. Sabatelli; E. E. Waltl; C. G. Alvero; G. Hess; P. Riedell; K. Kim; D. Brixner; G. Salles (HemaSphere, 2022)